Cargando…

Osteoporosis treatment in Austria—assessment of FRAX-based intervention thresholds for high and very high fracture risk

SUMMARY: The adoption of the management pathway proposed by the National Osteoporosis Guideline Group (NOGG), UK applied using the Austrian FRAX® tool in a referral population of Austrian women categorises 22–29% of women age 40 years or more eligible for treatment of whom 28–34% are classified at v...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dimai, Hans P., Johansson, Helena, Harvey, Nicholas C., Lorentzon, Mattias, Liu, Enwu, Vandenput, Liesbeth, Fahrleitner-Pammer, Astrid, Pietschmann, Peter, Muschitz, Christian, McCloskey, Eugene V., Kanis, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649455/ https://www.ncbi.nlm.nih.gov/pubmed/36357621 http://dx.doi.org/10.1007/s11657-022-01175-w

Ejemplares similares

FRAX-Based Intervention Thresholds for Osteoporosis Treatment in Ukraine
por: Povoroznyuk, Vladyslav, et al.
Publicado: (2021)

Use of age-dependent FRAX-based intervention thresholds for Singapore
por: Kanis, John A., et al.
Publicado: (2020)

Incidence of hip fracture in Saudi Arabia and the development of a FRAX model
por: Saleh, Yousef A. L., et al.
Publicado: (2022)

Epidemiology of hip fracture in Qatar and development of a country specific FRAX model
por: Abdulla, Nabeel, et al.
Publicado: (2022)

Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability—results from the Women’s Health Initiative hormone therapy trials
por: Lorentzon, Mattias, et al.
Publicado: (2022)

FRAX-based fracture probabilities in South Africa
por: Johansson, Helena, et al.
Publicado: (2021)

Hemoglobin Levels Improve Fracture Risk Prediction in Addition to FRAX Clinical Risk Factors and Bone Mineral Density
por: Jaiswal, Raju, et al.
Publicado: (2023)

Temporal changes in access to FRAX® in Thailand between 2010 and 2018
por: Chotiyarnwong, Pojchong, et al.
Publicado: (2019)

A surrogate FRAX model for Pakistan
por: Naureen, G., et al.
Publicado: (2021)

Potential Adverse Effect of Nonsteroidal Anti‐Inflammatory Drugs (NSAIDs) on Bisphosphonate Efficacy: An Exploratory Post Hoc Analysis From a Randomized Controlled Trial of Clodronate
por: Zheng, Zhangan, et al.
Publicado: (2022)

A new FRAX model for Brazil
por: Albergaria, B. H., et al.
Publicado: (2023)

Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures
por: McCloskey, E. V., et al.
Publicado: (2020)

Epidemiology of hip fractures in Bulgaria: development of a country-specific FRAX model
por: Kirilova, E., et al.
Publicado: (2020)

A surrogate FRAX model for the Kyrgyz Republic
por: Lesnyak, O., et al.
Publicado: (2020)

Analysis of Comorbidities, Clinical Outcomes, and Parathyroidectomy in Adults With Primary Hyperparathyroidism
por: Axelsson, Kristian F., et al.
Publicado: (2022)

Prescreening for Osteoporosis With Quantitative Ultrasound in Postmenopausal White Women
por: Steiner, Bernhard, et al.
Publicado: (2018)

Adjusting FRAX Estimates of Fracture Probability Based on a Positive Vertebral Fracture Assessment
por: Ye, Carrie, et al.
Publicado: (2023)

Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX
por: Johansson, L., et al.
Publicado: (2022)

Thirty years of hip fracture incidence in Austria: is the worst over?
por: Dimai, Hans Peter, et al.
Publicado: (2021)

Greater pQCT Calf Muscle Density Is Associated with Lower Fracture Risk, Independent of FRAX, Falls and BMD: A Meta‐Analysis in the Osteoporotic Fractures in Men (MrOS) Study
por: Harvey, Nicholas C., et al.
Publicado: (2022)

FRAX™ and the assessment of fracture probability in men and women from the UK
por: Kanis, J. A., et al.
Publicado: (2008)

Epidemiology of osteoporotic fracture in Kazakhstan and development of a country specific FRAX model
por: Issayeva, S., et al.
Publicado: (2020)

Diagnose und Therapie der Osteoporose bei Patienten mit chronischer Niereninsuffizienz: Gemeinsame Leitlinie der Österreichischen Gesellschaft für Knochen- und Mineralstoffwechsel (ÖGKM), der Österreichischen Gesellschaft für Physikalische Medizin und Rehabilitation (ÖGPMR) und der Österreichischen Gesellschaft für Nephrologie (ÖGN)
por: Cejka, Daniel, et al.
Publicado: (2022)

Epidemiology of osteoporotic fracture in Moldova and development of a country-specific FRAX model
por: Zakroyeva, Alla, et al.
Publicado: (2020)

Intervention thresholds and diagnostic thresholds in the management of osteoporosis
por: Kanis, John A., et al.
Publicado: (2022)

Bone - a casualty of ICU survival?
por: Amrein, Karin, et al.
Publicado: (2015)

Epidemiology of hip fracture and the development of a FRAX model for Uzbekistan
por: Lesnyak, O, et al.
Publicado: (2020)

Epidemiology of hip fracture and the development of FRAX in Ukraine
por: Povoroznyuk, VV, et al.
Publicado: (2017)

Osteoporosis in Europe: a compendium of country-specific reports
por: Willers, Carl, et al.
Publicado: (2022)

SCOPE 2021: a new scorecard for osteoporosis in Europe
por: Kanis, John A., et al.
Publicado: (2021)

Predictive Value of DXA Appendicular Lean Mass for Incident Fractures, Falls, and Mortality, Independent of Prior Falls, FRAX, and BMD: Findings from the Women's Health Initiative (WHI)
por: Harvey, Nicholas C, et al.
Publicado: (2021)

Assessing the effects of long-term osteoporosis treatment by using conventional spine radiographs: results from a pilot study in a sub-cohort of a large randomized controlled trial
por: Dimai, Hans Peter, et al.
Publicado: (2018)

Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX
por: Harvey, N. C., et al.
Publicado: (2015)

A country-specific FRAX model for Botswana
por: Kebaetse, M., et al.
Publicado: (2021)

Mikkeli Osteoporosis Index Identifies Fracture Risk Factors and Osteoporosis and Intervention Thresholds Parallel with FRAX
por: Waris, Ville Juhana, et al.
Publicado: (2011)

FGF23 in Acute and Chronic Illness
por: Schnedl, Christian, et al.
Publicado: (2015)

Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
por: Chandran, M., et al.
Publicado: (2020)

Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability
por: McCloskey, E. V., et al.
Publicado: (2019)

Epidemiology and economic burden of fragility fractures in Austria
por: Muschitz, C., et al.
Publicado: (2021)

Corrigendum to “Mikkeli Osteoporosis Index Identifies Fracture Risk Factors and Osteoporosis and Intervention Thresholds Parallel with FRAX”
por: Waris, Ville Juhana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ndffai5cf0snh9o5mscu3b1qg5